The 9th Pharma Pricing, Reimbursement & Market Access 2025 is a conference dedicated to an overview of global pricing, market access systems and cost management techniques.
Topics
US policy challenges for market access: Stepping ahead, especially during this Covid19
Formulating your best market access strategy during the pandemic
Unrivalled opportunity to expose and address the market access challenges facing the industry
How to capture and quantify patient value?
Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access
The role of Real World Evidence (RWE) in Oncology
Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment
Understanding - payers’ perspective
How can payers and industry work together to ensure that innovative and valuable treatments make it to the market?
Creating a robust patient services and reimbursement support program for biosimilar products
Advocating and collaborating with payers for value in a new era
Understand how price affects market access and learn on how to set prices for optimal access and returns.
Prioritising Patients! - Adding value through an innovative patient-centered approach
Evidence Generation - The strategic rigor and creativity applied to evidence generation
New drugs are failing to gain reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
Developing risk-sharing reimbursement models and value based pricing
Impact of social media and digital analytics
Explaining how to use the data sources and observational research for effective safety analysis
Patient engagement and adherence within the environment
Be part of a major networking opportunity
Dwell ahead of regulatory developments & improving your strategies in a cost effective way Accelerating new medicine introduction in developing world & overcoming challenges
